利用拉丁美洲国家哨点监测数据识别轮状病毒疫苗对住院影响的特征
研究利用六个拉丁美洲国家2004至2017年的标准化哨点轮状病毒监测数据,采用随机效应模型、谐波回归模型及重心分析、小波分析等方法,评估疫苗引入后轮状病毒相关住院比例与数量的变化及季节性改变。所有国家轮状病毒阳性急性腹泻样本比例均下降,平均降低16%(95%CI:10-22%),疫苗覆盖率每增加10%与轮状病毒阳性病例数下降相关。
要点
- 所有国家轮状病毒阳性急性腹泻样本比例均下降,平均降低16%(95%CI:10-22%)。
- 疫苗覆盖率每增加10%,轮状病毒阳性病例数下降幅度从洪都拉斯的4.3%(1.3-7.2%)到委内瑞拉的21.4%(16.8-25.9%)不等。
- 危地马拉、洪都拉斯和委内瑞拉疫苗引入后轮状病毒发病率季节性高峰强度减弱,高峰在监测年度内后移,尤其在高死亡率国家。
核心结论
- 被动监测数据虽存在监测力度变化等重要局限,但结合多种方法可识别轮状病毒疫苗影响的共同特征,包括总体效果及季节性动态变化。
研究设计与样本
- 使用玻利维亚、萨尔瓦多、危地马拉、洪都拉斯、巴拉圭和委内瑞拉六个拉丁美洲国家2004至2017年标准化哨点轮状病毒监测网络数据。
- 采用随机效应模型评估疫苗引入后轮状病毒相关住院比例的变化,采用谐波回归模型估计疫苗对轮状病毒住院数量的影响并控制轮状病毒阴性病例趋势,采用重心分析、小波分析和谐波回归评估轮状病毒季节性变化。
主要发现
- 所有国家均观察到轮状病毒阳性急性腹泻样本比例下降,平均降低16%(95%CI:10-22%)。
- 疫苗覆盖率每增加10%,轮状病毒阳性病例数下降幅度从洪都拉斯的4.3%(95%CI:1.3-7.2%)到委内瑞拉的21.4%(95%CI:16.8-25.9%)不等。
- 危地马拉、洪都拉斯和委内瑞拉疫苗引入后轮状病毒发病率季节性高峰强度减弱。
- 季节性高峰在监测年度内后移,尤其在高死亡率国家。
关键数值与推荐
- 平均轮状病毒阳性急性腹泻样本比例降低16%(95%CI:10-22%)。
- 疫苗覆盖率每增加10%对应的轮状病毒阳性病例数下降:洪都拉斯4.3%(95%CI:1.3-7.2%),委内瑞拉21.4%(95%CI:16.8-25.9%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 被动监测数据常存在重要局限,如监测力度的变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Passive surveillance data are often the only available source of data that can be used to evaluate the population-level impact of vaccination, but such data often suffer from important limitations such as changes in surveillance efforts. This study provides an example of how to identify important signatures of rotavirus vaccine impact, including evaluating the overall effectiveness and changes in rotavirus seasonal dynamics. METHODS: We used data from a standardized sentinel rotavirus surveillance network in six Latin American countries (Bolivia, El Salvador, Guatemala, Honduras, Paraguay, and Venezuela) from 2004 to 2017. A random-effects model was used to evaluate changes in the proportion of rotavirus-associated hospitalizations following vaccine introduction. Harmonic regression models were used to estimate vaccine impact on the number of rotavirus hospitalizations, controlling for trends in rotavirus-negative cases. Changes to rotavirus seasonality were evaluated using center of gravity analysis, wavelet analysis, and harmonic regression. RESULTS: All countries observed declines in the proportion of rotavirus-positive acute diarrhea samples with a mean reduction of 16% (95% confidence interval: 10-22%). We estimate that each 10% increase in vaccine coverage was associated with declines in the number of rotavirus-positive cases, ranging from 4.3% (1.3-7.2%) in Honduras to 21.4% (16.8-25.9%) in Venezuela. The strength of the seasonal peak in rotavirus incidence became smaller after vaccine introduction in Guatemala, Honduras, and Venezuela. Seasonal peaks also shifted later in the surveillance year, especially in higher-mortality countries. CONCLUSIONS: The combination of methods we applied have different strengths that allow us to identify common signatures of rotavirus vaccine impact.
引用
- Shioda K, de Oliveira LH, Sanwogou J, et al. Identifying signatures of the impact of rotavirus vaccines on hospitalizations using sentinel surveillance data from Latin American countries. Vaccine. 2019. PMID: 31672333. doi:10.1016/j.vaccine.2019.10.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。